LHC Group, Inc. (NASDAQ:LHCG) Holding Boosted by Virginia Retirement Systems ET AL

LHC Group, Inc. (NASDAQ:LHCG) Holding Boosted  by Virginia Retirement Systems ET AL

Virginia Retirement Systems ET AL increased its holdings in shares of LHC Group, Inc. (NASDAQ:LHCG) by 83.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,800 shares of the health services provider’s stock after acquiring an additional 10,400 shares during the quarter. Virginia Retirement Systems ET AL owned about 0.07% of LHC Group worth $2,348,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. BlackRock Inc. increased its holdings in shares of LHC Group by 76.9% during the 2nd quarter. BlackRock Inc. now owns 4,619,436 shares of the health services provider’s stock worth $395,377,000 after acquiring an additional 2,008,433 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in LHC Group by 74.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,133,200 shares of the health services provider’s stock valued at $182,581,000 after buying an additional 911,625 shares in the last quarter. FMR LLC grew its holdings in LHC Group by 297.8% in the 2nd quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after buying an additional 861,952 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in LHC Group by 162.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock valued at $60,897,000 after buying an additional 439,947 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in LHC Group by 51.7% in the 2nd quarter. Northern Trust Corp now owns 572,094 shares of the health services provider’s stock valued at $48,966,000 after buying an additional 194,902 shares in the last quarter. 87.82% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have commented on LHCG. SunTrust Banks upped their price objective on LHC Group to $115.00 and gave the company a “buy” rating in a report on Thursday, September 13th. Cantor Fitzgerald began coverage on LHC Group in a report on Wednesday, September 12th. They issued an “overweight” rating and a $117.00 price objective on the stock. BidaskClub raised LHC Group from a “hold” rating to a “buy” rating in a report on Thursday, August 16th. Bank of America set a $119.00 price objective on LHC Group and gave the company a “buy” rating in a report on Tuesday, September 18th. Finally, William Blair reaffirmed a “buy” rating on shares of LHC Group in a report on Thursday, November 1st. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. LHC Group currently has a consensus rating of “Buy” and an average target price of $105.92.

Shares of LHCG stock traded up $0.17 on Wednesday, hitting $104.83. 335,094 shares of the company’s stock were exchanged, compared to its average volume of 249,551. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. LHC Group, Inc. has a 12 month low of $58.65 and a 12 month high of $107.51. The company has a market cap of $3.29 billion, a P/E ratio of 43.32, a P/E/G ratio of 1.76 and a beta of 0.78.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, hitting the consensus estimate of $0.95. The business had revenue of $507.00 million during the quarter, compared to the consensus estimate of $515.03 million. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. LHC Group’s revenue for the quarter was up 88.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.64 EPS. As a group, equities research analysts anticipate that LHC Group, Inc. will post 3.52 earnings per share for the current fiscal year.

In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total value of $7,132,500.00. Following the completion of the transaction, the chief executive officer now directly owns 200,765 shares in the company, valued at $19,092,751.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jeff Reibel sold 5,239 shares of the stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $105.26, for a total value of $551,457.14. The disclosure for this sale can be found here. Insiders sold 157,995 shares of company stock valued at $15,712,683 over the last quarter. Corporate insiders own 6.80% of the company’s stock.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Story: How to calculate the intrinsic value of a stock

Related posts

Leave a Comment